The monocyte transcriptome during pregnancy in multiple sclerosis: prominent expression of the Fc-receptor CD64

Rinze Neuteboom, Evert Verbraak, Annet Wierenga - Wolf, Jane Voerman, M van Meurs, Sigrid Swagemakers, Peter van der Spek, Eric Steegers, CJA de Groot, Jon Laman, Rogier Hintzen

Research output: Contribution to journalArticleAcademic

6 Citations (Scopus)


Background: During the third trimester of pregnancy multiple sclerosis (MS) disease activity is reduced. It is not fully understood which factors mediate this disease amelioration. Objective: To study alterations of the monocyte transcriptome during pregnancy in MS patients, using a genomewide approach to identify differentially regulated genes. Methods: Women with MS and healthy controls were longitudinally studied, including a visit before pregnancy. Results: RNA-microarray analysis was performed in six patients. We found a significant increase of CD64 (Fc gamma receptor 1a, FcgR1a) during the third trimester compared with baseline, confirmed by RT-PCR in a group of ten patients. Analysis with Ingenuity software was performed using all genes expression of which was altered at least 1.5-fold in at least five out of six patients. Major networks that were altered during MS pregnancy were: cell-to-cell signalling and interaction, immune response, and cell signalling. From the genes selected for Ingenuity analysis, seven additional candidate genes, selected for their biological interest, were tested using RT-PCR in ten patients with MS and nine controls. We found an increased expression of JAK2 and STAT1 directly postpartum in patients with MS and in controls. Conclusion: The increased CD64 expression during pregnancy is indicative of enhanced innate immune functions.
Original languageUndefined/Unknown
Pages (from-to)389-396
Number of pages8
JournalMultiple Sclerosis
Issue number4
Publication statusPublished - 2011

Research programs

  • EMC MGC-02-02-01
  • EMC MGC-02-52-01-A
  • EMC MM-02-72-02
  • EMC MM-04-44-02

Cite this